Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition.
Targeted Inhibition of the miR-199a/214 Cluster by CRISPR Interference Augments the Tumor Tropism of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells under Hypoxic Condition.
复制标题
DOI:
10.1155/2016/3598542
复制
发表时间:
2016
影响因子:
4.3
通讯作者:
Zhu D
中科院分区:
文献类型:
--
作者:
Luo Y;Xu X;An X;Sun X;Wang S;Zhu D
The human induced pluripotent stem cell (hiPSC) provides a breakthrough approach that helps overcoming ethical and allergenic challenges posed in application of neural stem cells (NSCs) in targeted cancer gene therapy. However, the tumor-tropic capacity of hiPSC-derived NSCs (hiPS-NSCs) still has much room to improve. Here we attempted to promote the tumor tropism of hiPS-NSCs by manipulating the activity of endogenous miR-199a/214 cluster that is involved in regulation of hypoxia-stimulated cell migration. We first developed a baculovirus-delivered CRISPR interference (CRISPRi) system that sterically blocked the E-box element in the promoter of the miR-199a/214 cluster with an RNA-guided catalytically dead Cas9 (dCas9). We then applied this CRISPRi system to hiPS-NSCs and successfully suppressed the expression of miR-199a-5p, miR-199a-3p, and miR-214 in the microRNA gene cluster. Meanwhile, the expression levels of their targets related to regulation of hypoxia-stimulated cell migration, such as HIF1A, MET, and MAPK1, were upregulated. Further migration assays demonstrated that the targeted inhibition of the miR-199a/214 cluster significantly enhanced the tumor tropism of hiPS-NSCs both in vitro and in vivo. These findings suggest a novel application of CRISPRi in NSC-based tumor-targeted gene therapy.
登录
查看更多内容
影响因子:
9
作者:
通讯作者:
--
影响因子:
33.5
作者:
Luo Y;Zhu D;Du R;Gong Y;Xie C;Xu X;Fan Y;Yu B;Sun X;Chen Y
通讯作者:
Chen Y
影响因子:
4.6
作者:
Chang H;Yi B;Ma R;Zhang X;Zhao H;Xi Y
通讯作者:
Xi Y
影响因子:
14.9
作者:
Ho TT;Zhou N;Huang J;Koirala P;Xu M;Fung R;Wu F;Mo YY
通讯作者:
Mo YY
DOI:
10.1038/mtm.2015.50
发表时间:
2016
期刊:
Molecular therapy. Methods & clinical development
影响因子:
--
作者:
Kwang TW;Zeng X;Wang S
通讯作者:
Wang S